Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2024-03-04 00:00:00 ET · period of report 2024-02-29 · accession 0000874015-24-000125 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-04 | 2024-02-29 | IONS | Monia Brett P | CEO Level 15, Dir | J - Other | $34.43 | +538 | 174.3K | +0.3% | +$18.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-29 | J | A | 538 | $34.43 | 174,289 | D | — | — |